Jakafi 15 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FX7G3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,774
Award facts
- Contract value 100% obligated
- $11,773.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,773.87 contract is to provide the drug Jakafi (ruxolitinib) 15 mg tablets to support the medical supply needs of military healthcare facilities. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which covers a comprehensive range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The contract does not have any set-aside designation, allowing DMS Pharmaceutical Group to leverage its small business and woman-owned status to secure direct federal awards across multiple pharmaceutical product categories.
Quick answers
Who was awarded contract SPE2DB25FX7G3?
SPE2DB25FX7G3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 4, 2024.
How much is contract SPE2DB25FX7G3 worth?
The government has obligated $11,774 on SPE2DB25FX7G3.
Is contract SPE2DB25FX7G3 an order under another contract?
Yes. SPE2DB25FX7G3 is a delivery order under SPE2DB20D9354, an indefinite delivery contract.
Was contract SPE2DB25FX7G3 competed?
The extent of competition for SPE2DB25FX7G3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award